Tasigna, New Drug For CML

October 30, 2007 by MedHeadlines  
Filed under Cancer, Drugs

Med Headlines - The Food and Drug Administration has approved Tasigna (nilotinib), a new drug for the treatment of Chronic Myeloid Leukemia (CML). Tasigna has been developed by Novartis AG. Read more

-->

Polls

  • Should healthcare professionals, who oppose abortion for moral reasons, be forced to perform the procedure anyway?

    View Results

    Loading ... Loading ...

Editor's Picks

alt text Did Marrow Transplant Cure AIDS?

That’s the question abuzz in the medical community as doctors around the globe...

alt text Fan In Baby’s Room Reduces Risk of SIDS

One of the most heartbreaking and frustrating diagnoses discussed today is that of...

alt text Top Economist Says McCain’s Health Plan Better for More Americans

In a Wall Street Journal (WSJ) opinion piece, one of the nation’s top economists...

More Editor's Picks
    End, comment out -->